Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. May 21, 2024; 30(19): 2523-2537
Published online May 21, 2024. doi: 10.3748/wjg.v30.i19.2523
Table 2 Demographic and clinical manifestations of adult autoimmune enteropathy patients
Onset age (yr)45.5 (IQR: 30.8-53.5)
Diarrhea duration (months)4.0 (IQR: 2.0-6.0)
Weight loss (kg)17.0 (IQR: 11.3-29.0)
BMI (kg/m2)17.9 (IQR: 16.4-19.1)
Vomit81% (13/16)
Abdominal pain50% (8/16)
Fever50% (8/16)
Hypovolemic shock38% (6/16)
Wernicke encephalopathy19% (3/16)
Acute kidney injury50% (8/16)
AnemiaAnemia81% (13/16)
Mild44% (7/16)
Moderate31% (5/16)
Severe6% (1/16)
Hypoalbuminemia88% (14/16)
Electrolyte disturbanceHypokalemia94% (15/16)
Hyponatremia69% (11/16)
Hypocalcemia94% (15/16)
Hypomagnesemia44% (4/9)
Endocrine disordersThyroid dysfunction14% (2/14)
Abnormal blood glucose0% (0/14)
Inflammatory indicatorsElevated WBC75% (12/16)
Elevated hsCRP50% (8/16)
Elevated ESR50% (8/16)
Liver functionElevated ALT50% (8/16)
Fecal OB testPositive81% (13/16)
Negative19% (3/16)
Fecal Sultan III stainingPositive56% (9/16)
Negative44% (7/16)
D-xylose absorption testPositive100% (13/13)
ComplementDecreased C373% (11/15)
Decreased C47% (1/15)
IgAElevated25% (4/16)
Normal75% (12/16)
IgMElevated6% (1/16)
Decreased25% (4/16)
Normal69% (11/16)
IgGElevated19% (3/16)
Normal81% (13/16)
IgEElevated43% (3/7)
Normal57% (4/7)
AE antibody0% (0/2)
AG antibody0% (0/6)
Other antibodiesCeliac8% (1/13)
ANA7% (1/14)
ANCA8% (1/13)